The latest research study „Contrast Media Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“ by IMARC Group, finds that the global contrast media market size reached US$ 4.27 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.59 Billion by 2027, exhibiting a growth rate (CAGR) of 4.40% during 2022-2027.
Contrast media represents substances that are utilized to improve the contrast of the structures of fluids in the body during the process of medical imaging. They are available in numerous product variants, including iodinated, barium-based, gadolinium-based microbubble, etc. These contrast media materials enhance the visibility of targeted issues and the structure of blood vessels. They even absorb or alter ultrasound or electromagnetism, which emits radiation themselves. Consequently, contrast media products find extensive applications in hospitals and clinics across countries.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/contrast-media-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into thereport.
Contrast Media Market Trends and Drivers:
The expanding geriatric population and the increasing prevalence of various chronic ailments, such as cancer, cardiovascular diseases, and neurological disorders, are primarily driving the contrast media market. Besides this, the inflating investments in research and development (R&D) projects and the growing merger and acquisition activities among leading market players to innovate new products are further stimulating the market growth. In addition to this, the shifting preferences toward image-directed diagnostics procedures for effective results and the elevating technological advancements in medical imaging are acting as significant growth-inducing factors.
Apart from this, the launch of favorable policies by government bodies, especially in developing countries, to enhance the healthcare infrastructure and the escalating number of angioplasty procedures that require iodinated contrast media are also positively influencing the global market. Furthermore, the emerging trend of minimally invasive surgeries (MID) among patients and medical professionals, on account of several advantages, including faster recovery time, lower stress on the immune system, reduced stress on the immune system, shortened hospital stays, etc., and the rising patent expiry of multiple branded products are expected to stimulate the contrast media market over the forecasted period.
Report Coverage:
Report Features | Details |
---|---|
Base Year of the Analysis | 2021 |
Historical Period | 2016-2021 |
Forecast Period | 2022-2027 |
Units | US$ Billion |
Segment Coverage | Type, Modality, Application, Route of Administration, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Bayer AG, Beijing Beilu Pharmaceuticals Company Limited, Bracco S.p.A., General Electric Company, Guerbet, iMAX Diagnostic Imaging Limited, J.B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus, Nano Therapeutics Pvt Ltd, SANOCHEMIA Pharmazeutika GmbH, TAEJOON PHARM Co. Ltd. and Trivitron Healthcare. |
Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Bayer AG, Beijing Beilu Pharmaceuticals Company Limited, Bracco S.p.A., General Electric Company, Guerbet, iMAX Diagnostic Imaging Limited, J.B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus, Nano Therapeutics Pvt Ltd, SANOCHEMIA Pharmazeutika GmbH, TAEJOON PHARM Co. Ltd. and Trivitron Healthcare.
The report has segmented the market on the basis of type, modality, application, route of administration and end user.
Type:
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
- Barium-based Contrast Media
Modality:
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound
Application:
- Radiology
- Interventional Radiology
- Interventional Cardiology
Route of Administration:
- Intravenous/Intrarterial
- Oral Route
- Rectal Route
- Others
End User:
- Hospital, Clinics and Ambulatory Surgery Centers
- Diagnostic Imaging Centers
Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Contrast Media Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Iodinated Contrast Media
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Gadolinium-based Contrast Media
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Microbubble Contrast Media
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Barium-based Contrast Media
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Modality
7.1 X-ray/Computed Tomography (CT)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Magnetic Resonance Imaging (MRI)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ultrasound
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Radiology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Interventional Radiology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Interventional Cardiology
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Intravenous/Intrarterial
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral Route
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Rectal Route
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Hospital, Clinics and Ambulatory Surgery Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Diagnostic Imaging Centers
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Bayer AG
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Beijing Beilu Pharmaceuticals Company Limited
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 Bracco S.p.A.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 SWOT Analysis
16.3.4 General Electric Company
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Guerbet
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 iMAX Diagnostic Imaging Limited
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 J.B. Chemicals & Pharmaceuticals Limited
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.8 Jodas Expoim Pvt. Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Lantheus
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Nano Therapeutics Pvt Ltd
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 SANOCHEMIA Pharmazeutika GmbH
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 TAEJOON PHARM Co. Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Trivitron Healthcare
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
also Read; https://www.couponkaka.com/advanced-packaging-market-size-share-growth-and-forecast-to-2022-27/